Guess which ASX medical tech share soared 37% at one point today

We take a look at why this medical technology company soared ahead today.

| More on:
Person pointing at an increasing blue graph which represents a rising share price.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • This one medical technology company soared 37% today before pulling back slightly  
  • The company's share price finished the day nearly 26% in the green 
  • The company secured a major investment from a global x-ray manufacturer 

The Micro-X Ltd (ASX: MX1) share price exploded today on news of a $15 million investment.

Micro-X shares surged 37% from 13.5 cents to 18.5 cents before retreating. The company's shares finished the day up 26%.

Let's take a look at what this ASX medical tech share reported.

New strategic partnership

Micro-X has formed a strategic partnership with Varex Imaging Corporation (NASDAQ: VREX). Varex is said to be the biggest independent manufacturer of x-ray technology components in the world.

Varex will pay Micro-X US$5 million (about A$7.5 million) for a global exclusive licence to use Micro-X's NEX technology. Under the deal, Varex will be able to design, make and sell multi-beam x-ray tubes using this technology.

Further, Varex will take a 9.9% stake in Micro-X via a share placement of 50,709,000 shares at 14.7 cents per share. This investment is valued at nearly $7.5 million. In total, this would take Varex's investment in Micro-X to about $15 million.

Commenting on the news, Micro-X managing director Peter Rowland said:

This long-term investment will continue to promote Micro-X on the world stage, as a leader in innovative products and technology that is designed to make lives better.

This collaboration contributes hugely to our future growth and allows us to continue to focus on future medical and security imaging applications for our proprietary NEX Technology

Micro-X is holding an investor call at 9am on Tuesday to discuss this news.

Micro-X share price snapshot

The Micro-X share price has slid 42% in the past year, while it has fallen 33% year to date.

For perspective, the S&P/ASX 200 Health Care Index (ASX: XHJ) has fallen nearly 14% in a year.

Micro-X has a market capitalisation of about $78 million based on the current share price.

Motley Fool contributor Monica O'Shea has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Donor donates blood in medical clinic. Beautiful European woman of 30 years sits in medical chair looking into camera and smiling.
Healthcare Shares

Will CSL shares rise in value over the next 12 months? Here's what the experts say

Can CSL have a better year in FY2025?

Read more »

ANZ ASX 200 banks capital return Group of investors madly grabbing for cash on city street.
Healthcare Shares

ResMed shares rebounding as investors rush to buy the dip

ResMed is rising as ASX investors buy the dip following yesterday's 13% share price dive.

Read more »

A fit man flexes his muscles, indicating a positive share price movement on the ASX market
ETFs

How to invest in US weight loss drug stocks on the ASX

Want to buy shares in the maker of Ozempic? There's an ASX ETF for that.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Healthcare Shares

ResMed share price plunges 13% as weight-loss results reawaken worries

Why are investors heading to the exits today? Let's see what's happening.

Read more »

Exhausted young Caucasian woman lying on comfortable sofa in living room sleeping after hard-working day, tired millennial female fall asleep on couch at home, take nap or daydream, fatigue concept
Healthcare Shares

ResMed shares are in a two-month lull. Is this a chance to buy?

ResMed shares are still trading below the price targets of several brokers.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Healthcare Shares

Botanix shares jump on FDA approval and $70m capital raising

Investors are responding positively to some very big news.

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

If you invested $5,000 in this ASX healthcare stock a year ago, you'd have $50,833 now!

The little-known ASX healthcare stock has delivered eye-watering 12-month gains. But how?

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Botanix Pharmaceuticals share price on watch amid FDA news and 'transformative event'

Big news has just been announced from this clinical dermatology company.

Read more »